Literature DB >> 6463564

Acute effect of exogenous thyroxine dose on serum thyroxine and thyrotrophin levels in treated hypothyroid patients.

E Soppi, K Irjala, H L Kaihola, J Viikari.   

Abstract

Acute effects of exogenous thyroxine on the serum thyroxine (T4), free thyroxine (FT4) and thyrotrophin (TSH) levels were studied in 20 hypothyroid women during the long-term maintenance therapy. All patients were euthyroid by clinical and laboratory parameters (T4). In nine patients TSH secretion was totally suppressed (less than 1 mu/l) by the mean dose of 178 micrograms thyroxine. Eleven patients had TSH values greater than 1 mu/l. Their mean thyroxine dose (132 micrograms) was not significantly lower than that which totally suppressed the TSH secretion. Ingestion of thyroxine resulted in maximal T4 and FT4 levels at 2 h after taking the drug. Simultaneously TSH concentration reached its minimum. The results indicate that it is necessary to know when the patient has taken the thyroxine in relation to determination of T4, FT4 and TSH levels in order to make the right decisions about the substitution dose of thyroxine. Thus it is essential to take blood sample for hormone determination before the patient ingests the daily thyroxine dose. However, among hypothyroid patients substituted by thyroxine there are individuals whose TSH secretion is not suppressed by normal T4 and FT4 levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6463564     DOI: 10.3109/00365518409083819

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  2 in total

1.  Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis".

Authors:  P E Jennings; B P O'Malley; K E Griffin; B Northover; F D Rosenthal
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

2.  Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit.

Authors:  R Eggertsen; K Petersen; P A Lundberg; E Nyström; G Lindstedt
Journal:  BMJ       Date:  1988-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.